Organometallic Ligands

<p>Phe-Lys(Fmoc)-PAB is a chemical compound that belongs to the category of peptide-based prodrugs, which is derived from synthetic sources with a focus on targeted delivery. This compound consists of phenylalanine and lysine residues, where the lysine is modified with a fluorenylmethyloxycarbonyl (Fmoc) protecting group and a p-aminobenzyl (PAB) linker. The mode of action involves utilizing the stable peptide bond and the cleavable PAB linker to deliver active agents in a controlled fashion, usually by enzyme-mediated cleavage at the target site.</p>

<p>BMS-582949 is an investigational pharmaceutical compound, specifically a chemokine receptor antagonist, that has been derived through synthetic chemical processes. Its mode of action involves selectively inhibiting the C-C chemokine receptor type 2 (CCR2), a receptor involved in the migration and activation of monocytes and other immune cells. By blocking CCR2, BMS-582949 aims to modulate inflammatory pathways that are implicated in various diseases.</p>

<p>Obaa is an antimicrobial coating, which is a synthetic compound with engineered properties designed to inhibit bacterial growth. The source of this product is advanced chemical engineering, utilizing innovative formulations to create a stable, long-lasting barrier against microbial colonization. Its mode of action involves disrupting the cell membrane integrity of bacteria, leading to cell lysis and subsequent death of the microorganism.</p>

<p>Pf-04455242 hydrochloride is a selective phosphodiesterase 10A (PDE10A) inhibitor, which is derived synthetically. Its mode of action involves inhibiting the PDE10A enzyme, which plays a critical role in the regulation of intracellular cyclic nucleotides, particularly cyclic AMP and cyclic GMP, in the brain. By selectively targeting PDE10A, this compound modulates neurotransmission pathways that are implicated in psychiatric and neurological disorders.</p>

<p>CCT020312 is a small-molecule inhibitor that is a selective and potent inhibitor of the P21-activated kinase 4 (PAK4), which is sourced through synthetic organic chemistry. By inhibiting PAK4, this compound disrupts the signaling pathways that are often upregulated in various malignancies, involving proliferation, survival, and cytoskeletal reorganization. Through competitive binding at the ATP-binding site of PAK4, CCT020312 effectively suppresses kinase activity, which is crucial for downstream signaling events associated with oncogenic processes.</p>

<p>MKT-077 is a rhodacyanine dye analogue, which is a compound derived from the class of compounds known as rhodacyanines. This particular analogue is synthesized for its biochemical properties, specifically targeting mitochondrial functions. The mode of action of MKT-077 involves the selective accumulation within the mitochondria of cancer cells, where it induces mitochondrial stress and disrupts mitochondrial membrane potential. This disruption leads to apoptotic cell death, making it a potential agent in cancer treatment research.</p>

<p>Topfluor PI(4,5)P2 is a synthetic phosphoinositide, which is chemically modified to include a fluorophore for advanced biological research. It is derived from phosphatidylinositol 4,5-bisphosphate, a critical lipid found in eukaryotic cell membranes. The fluorophore allows researchers to visualize and track the behavior of phosphoinositides in real-time using fluorescence microscopy techniques.</p>

<p>VPC 23019 is an advanced herbicidal formulation, which is a synthetic chemical compound designed for effective weed control. This product is derived from a complex synthesis process involving multiple chemical precursors, optimized for high efficacy and low environmental persistence. The active ingredient in VPC 23019 targets specific enzymatic pathways in weed species, disrupting essential biological processes such as amino acid synthesis. This mode of action results in the inhibited growth and eventual death of the target plants, while minimizing impact on non-target species and surrounding ecosystems.</p>

<p>GW-406381 is a potent and selective agonist for the peroxisome proliferator-activated receptor delta (PPARδ), which is commonly employed in pharmacological research. This compound functions as a ligand that activates PPARδ, a nuclear receptor that plays a critical role in the regulation of lipid metabolism, energy homeostasis, and inflammatory responses. By binding to the PPARδ receptor, GW-406381 modulates the transcription of target genes involved in fatty acid oxidation, mitochondrial biogenesis, and muscle fiber type switching.</p>

<p>SAR 405 is a selective inhibitor, which is synthesized chemically, targeting the phosphatidylinositol 3-kinase catalytic subunit type 3 (PIK3C3), also known as Vps34. This inhibitor functions by specifically binding to the ATP-binding site of the kinase, thus blocking its catalytic activity. By inhibiting PIK3C3, SAR 405 disrupts phosphatidylinositol 3-phosphate (PI3P) production, a pivotal element in autophagy and endosomal trafficking processes.</p>

<p>YC-1 is an activator of soluble guanylate cyclase (sGC), derived from synthetic chemical sources, with a specific mode of action that inhibits the degradation of cyclic guanosine monophosphate (cGMP). By modulating the levels of cGMP, YC-1 affects various biological pathways associated with vasodilation, anti-platelet aggregation, and anti-inflammatory effects.</p>

<p>Nada is a delactosed fermented dairy beverage, derived from milk sources, with live probiotic cultures as its mode of action. These cultures primarily include strains such as Lactobacillus acidophilus and Bifidobacterium bifidum, known for their ability to promote gut health by modulating the intestinal microbiota, enhancing gut barrier function, and modulating the immune response.</p>

<p>RLLFT-NH2 is a synthetic neuropeptide, which is designed to mimic naturally occurring neuropeptides with potential modulatory effects in the central nervous system. It is sourced through chemical synthesis, allowing for precise control over its amino acid sequence and modifications. The mode of action of RLLFT-NH2 involves interaction with specific neuropeptide receptors, potentially altering neurotransmission pathways, thereby affecting neural signaling and plasticity.</p>

<p>S 32212 hydrochloride is a selective serotonin receptor antagonist, which is synthesized chemically. Its mode of action involves the selective binding and inhibition of serotonin receptors in the brain, particularly those involved in the modulation of mood, anxiety, and other neurological processes. By targeting these receptors, S 32212 hydrochloride influences serotonin pathways, providing insights into potential therapeutic strategies for neuropsychiatric conditions.</p>

<p>dFKBP-1 is a heat shock protein derived from Drosophila melanogaster, which is commonly used as a model organism in genetic and molecular biology research. This protein, known as Drosophila FK506-binding protein 1 (dFKBP-1), originates from Drosophila and is involved in essential cellular processes.</p>

<p>Mac glucuronide phenol-linked SN-38 is a chemically engineered prodrug derived from irinotecan. This compound serves as a targeted therapeutic agent, designed to enhance the delivery and activation of SN-38, an active metabolite, at tumor sites. The source of this product arises from the selective conjugation of SN-38 with a glucuronide moiety, linked through a phenolic connector, enabling preferential release in the tumor microenvironment.</p>

<p>1-(3,4-Dimethoxyphenethylamino)-3-(3,4-dihydroxyphenoxy)-2-propanol is a synthetic beta-adrenergic blocking agent primarily utilized in scientific research. Derived from laboratory chemical synthesis, this compound is designed to mimic and antagonize the action of endogenous catecholamines on beta-adrenergic receptors. The compound's mode of action involves competitive inhibition of these receptors, reducing heart rate, cardiac output, and vasodilation effects typically mediated by adrenaline and noradrenaline.</p>

<p>MI-1061 is a bio-insecticide, which is microbially derived from the bacterium *Metarhizium anisopliae*. This environmentally friendly product utilizes the natural biological processes of its source organism, functioning primarily through spore ingestion by target insect pests. Upon ingestion, the spores germinate, leading to the proliferation of the fungus within the host insect, ultimately causing death through nutrient depletion and physical blockage.</p>

<p>Adriforant hydrochloride is a synthetic histamine H4 receptor antagonist, which is derived through chemical synthesis. This compound specifically targets the H4 receptor, a member of the histamine receptor family, playing a crucial role in the modulation of immune response and inflammatory processes. The mode of action of adriforant hydrochloride involves competitive inhibition of the H4 receptor, thereby blocking the signaling pathways that contribute to the recruitment and activation of immune cells, such as eosinophils and T cells, which are pivotal in allergic and inflammatory conditions.</p>

<p>CDM-NAG is a specialized biochemical substrate, which is a chemical compound derived from the structural modification of chitin. It has been engineered to act as a chromogenic or fluorescent marker due to its functional groups that undergo changes upon enzymatic action. The mode of action involves hydrolysis by N-acetylglucosaminidases, enzymes that recognize and cleave specific glycosidic bonds within the substrate. Upon enzymatic cleavage, CDM-NAG releases a measurable signal, either through colorimetric change or fluorescence, enabling precise quantification of enzyme activity.</p>

<p>Axitinib sulfoxide is a small molecule metabolite, which is derived from the parent compound axitinib. Axitinib, a tyrosine kinase inhibitor, targets vascular endothelial growth factor receptors (VEGFRs), primarily utilized in oncological therapeutics. The source of axitinib sulfoxide is the metabolic transformation of axitinib in vivo, involving the oxidation of sulfur atoms by hepatic metabolic enzymes, particularly cytochrome P450.</p>

<p>(E)-5-(4-Chlorophenyl)-3-phenylpent-2-enoic acid is an anti-inflammatory compound, which is synthesized through organic chemical processes. Its mode of action involves the inhibition of cyclooxygenase enzymes, thereby reducing the synthesis of pro-inflammatory mediators such as prostaglandins. This action is critical in diminishing inflammation and associated symptoms.</p>

<p>Myxochelin A is an iron-chelating siderophore, which is a specialized secondary metabolite produced by certain strains of myxobacteria. These microorganisms, often found in soil and decomposing material, synthesize Myxochelin A to scavenge iron from the environment, essential for their survival and growth. The mode of action of Myxochelin A involves the sequestration of ferric iron (Fe^3+) ions through its high-affinity binding sites. This effectively deprives competing microorganisms of the iron required for crucial biological processes, imparting an antimicrobial effect.</p>

<p>P-glycoprotein (MDR1) inhibitor; non-immunosuppressive cyclosporin A analog</p>

<p>AM 36 dihydrochloride is a synthetic cannabinoid receptor ligand, which is derived from chemical synthesis processes aimed at targeting specific receptors in the endocannabinoid system. With its action primarily focused on modulating cannabinoid receptor activity, AM 36 dihydrochloride interacts as an agonist or antagonist, depending on the receptor subtype and the biological context.</p>

<p>A-889425 is a novel small molecule compound that serves as a potent and selective antagonist. It is derived from synthetic chemical processes aimed at modulating ion channel activity specifically. The mode of action of A-889425 involves the selective inhibition of specific ion channels, which play critical roles in cellular signaling pathways and are implicated in various physiological processes.</p>

<p>PIM-447 dihydrochloride is a potent small molecule kinase inhibitor, which is synthesized as a selective inhibitor of PIM kinases. These kinases, part of the serine/threonine kinase family, are implicated in various cellular processes, including cell cycle progression and survival, making them a target of interest in oncology research. PIM-447 acts by binding to the ATP-binding pocket of PIM kinases, thereby inhibiting their activity and disrupting downstream signaling pathways that promote tumor growth and survival.</p>

<p>Bombinakinin-GAP is a neuropeptide, which is derived from the skin secretions of Bombina orientalis, a species of toad. This peptide's source is an amphibian, specifically extracted for its unique biochemical properties. Bombinakinin-GAP functions by interacting with specific receptors in the nervous system, modulating various physiological responses. Its mode of action involves binding to neurokinin receptors, influencing neural signal transmission.</p>

<p>AST-1306 is an irreversible inhibitor, which is a compound designed to target specific enzymes. It stems from advanced pharmaceutical research in the field of cancer therapeutics with a mechanism of targeting the epidermal growth factor receptor (EGFR) kinase. Through covalent bonding, AST-1306 effectively impairs the function of EGFR by forming a stable, permanent bond with its active site, leading to sustained suppression of downstream signaling pathways involved in cellular proliferation and survival.</p>

<p>SIS3 is a selective Smad3 inhibitor, which is a small-molecule compound derived through synthetic chemical methods. It is designed to specifically inhibit the phosphorylation and activity of the Smad3 protein, a critical transcription factor involved in the transforming growth factor-beta (TGF-β) signaling pathway. Smad3 is implicated in various cellular processes, including proliferation, differentiation, and apoptosis.</p>

<p>N-[(1S,2R,4S)-2-Amino-4-(dimethylcarbamoyl)cyclohexyl]-N'-(5-chloropyridin-2-yl)oxamide is a synthetic compound, which is an engineered chemical structure with potential pharmacological properties. This compound is sourced from systematic organic synthesis, employing targeted molecular adjustments to achieve a precise configuration that may interact with specific biological pathways. It operates by potentially modulating receptor activity or enzyme inhibition, although detailed mechanistic studies are necessary to fully elucidate its mode of action. Its unique configuration allows it to possibly interact with certain biomolecules, aiming to alter or inhibit pathological processes.</p>

<p>A potent Met kinase inhibitor (IC50 = 3.9 nM). Also inhibits Axl, Ron, and Tyro-3 (IC50 = 1.1, 1.8 and 4.3 nM, respectively). Anti-proliferative in Met-driven tumors in vitro and in vivo. Induces polyploidy in breast cancer cells and thereby chemoresistance.</p>

<p>CVT 6883 is a selective adenosine A2B receptor antagonist, which is synthesized through chemical processes designed to enhance specificity and efficacy for A2B receptor blockade. The mode of action involves the inhibition of the adenosine A2B receptor, preventing adenosine from binding and activating this receptor subtype. This inhibition can modulate various physiological and pathological processes since adenosine receptors play critical roles in inflammation and fibrosis.</p>

<p>Tyrphostin AG 1007 is a synthetic small molecule inhibitor, which is derived from chemical synthesis with a targeted mode of action on protein tyrosine kinases. These kinases are crucial enzymes involved in the signal transduction pathways that regulate various cellular processes, including cell growth, differentiation, and metabolism. By inhibiting these kinases, Tyrphostin AG 1007 interferes with aberrant signaling pathways often implicated in diseases such as cancer and inflammatory disorders.</p>

<p>Deltamethrin-d5 is a labeled pyrethroid isomer, which is an essential tool in analytical chemistry and environmental science. This product is synthetically derived and incorporates deuterium, a stable isotope of hydrogen, thereby serving as an internal standard in mass spectrometric analysis.</p>

<p>5-HT6 antagonist 29 is a pharmacological compound, which is synthesized through organic chemistry techniques, typically involving multi-step reactions to yield high specificity. This compound functions as a selective antagonist for the 5-HT6 serotonin receptor, a G-protein-coupled receptor predominantly found in the central nervous system.</p>

<p>Brl 15572 hydrochloride is a selective adenosine A2B receptor antagonist, which is a synthetic chemical compound designed for research purposes. It originates from the synthesis of pharmacological agents aimed at interfering with adenosine receptor-mediated pathways in human physiology. This compound acts by binding to the adenosine A2B receptors with high specificity, inhibiting their activity, and preventing the natural ligand, adenosine, from exerting its effects.</p>

<p>5-Phenacyloxy-2H-isoquinolin-1-one is a synthetic chemical compound, which is primarily utilized as a biochemical inhibitor. This compound is derived from isoquinolinone sources and is distinguished by its phenacyloxy moiety linking it to the isoquinolinone core structure. Its mechanism of action involves selectively inhibiting specific biological pathways, a characteristic that makes it a valuable tool in the study of enzyme regulation and signal transduction processes. By interfering with these pathways, 5-Phenacyloxy-2H-isoquinolin-1-one provides insights into cellular functions and the biochemical landscape.</p>

<p>3-(3,4-Dimethoxyphenyl)-N-[4-(trifluoromethyl)phenyl]-2-propenamide is a synthetic compound that belongs to the class of amides derived from 2-propenamide structures. It is primarily sourced from chemical synthesis processes involving the reaction of substituted phenyl groups with trifluoromethyl phenyl derivatives. The compound’s structural features allow it to engage in various interactions through its aromatic and polar functional groups.<br><br>In terms of its mode of action, this compound acts by potentially interacting with specific biological pathways, likely involving modulation of receptor activities or enzyme inhibition due to its molecular architecture. Such interactions can influence cellular responses and are of interest in the study of signal transduction and metabolic pathways.<br><br>The potential uses and applications of 3-(3,4-Dimethoxyphenyl)-N-[4-(trifluoromethyl)phenyl]-2-propenamide include research in pharmacology, specifically within the realms of understanding disease mechanisms and developing therapeutic agents. It may serve as a lead compound or molecular scaffold in the design of new drugs aimed at targeting specific proteins or pathways implicated in various diseases, including cancer, inflammatory disorders, and neurological conditions. Its applications are primarily experimental and aimed at elucidating biochemical pathways within cellular systems.</p>

<p>SPDH reacts with primary amines via its NHS ester and forms disulfide bonds via the pyridyldithiol group. The cleavage occurs intracellularly.</p>

<p>2'-Hydroxy-2,4,4',5,6'-pentamethoxychalcone is a chalcone compound, which is a type of flavonoid widely known for its diverse biological activities. This particular chalcone is sourced from natural plant origins, where it forms part of the plant's secondary metabolites. Its structure features a unique arrangement of methoxy and hydroxy groups, contributing to its distinctive biochemical properties.</p>

<p>NSC 135130 is a synthetic compound that serves as an antioxidant and anti-inflammatory agent. It is derived through chemical synthesis, a process involving the combination of various elements and compounds to produce a novel substance with specific desired properties. The mode of action of NSC 135130 primarily involves the scavenging of free radicals and modulation of inflammatory pathways, thus helping to mitigate oxidative stress and inflammation at the cellular level.</p>

<p>Desmethylene tadalafil is a chemical compound, specifically a designer analog of tadalafil, which is known for its phosphodiesterase type 5 (PDE5) inhibition. It is a synthetic derivative, often cited in contexts involving unauthorized erectile dysfunction treatments. Its mode of action involves the inhibition of the PDE5 enzyme, leading to increased levels of cyclic guanosine monophosphate (cGMP). This results in vasodilation and increased blood flow, particularly in the corpus cavernosum.</p>

<p>YHO-13351 is an investigational pharmaceutical compound classified as a small molecule inhibitor. It is synthesized through a series of complex chemical processes involving precise modifications and optimizations to achieve high specificity and potency. This compound operates by selectively inhibiting certain molecular pathways that are implicated in pathological conditions, particularly those involving aberrant cellular proliferation and survival mechanisms.</p>

<p>SKF83822 hydrobromide is a selective dopamine receptor agonist, which is synthetically derived with a specific affinity for dopamine D1 receptors. Its mode of action involves the targeting and activation of these receptors, offering a unique tool for research into dopamine-related signaling pathways. Due to its specificity, SKF83822 hydrobromide is utilized extensively in neuroscientific research to investigate the roles of D1 receptors in various physiological and pathological contexts.</p>

<p>BIX is an NHE1 inhibitor, which is a small molecule compound derived from chemical synthesis. It specifically targets the Na+/H+ exchanger 1 (NHE1), a protein involved in the regulation of intracellular pH. The mode of action of BIX involves the inhibition of NHE1, leading to altered proton exchange across the plasma membrane. This action affects the cellular pH homeostasis and ion balance, which can influence various cellular processes such as cell proliferation, apoptosis, and migration.</p>

<p>IMB-808 is an advanced synthetic compound, which is derived from a meticulously engineered chemical synthesis process. This compound functions through a unique mode of action that involves the disruption of microbial cell walls, leading to cell lysis and death. The precise mechanism involves the interference with enzymatic functions critical to cell wall biosynthesis, making it highly effective against a broad spectrum of bacterial pathogens.</p>

<p>SW203668 trifluoroacetate is a synthetic neuropeptide, which is a laboratory-derived analog of natural signaling molecules involved in neuronal communication. It is sourced from chemical synthesis, designed to mimic or enhance the function of endogenous peptides by binding to specific receptors on cell surfaces. The mode of action of SW203668 trifluoroacetate involves the modulation of neurotransmitter release and the subsequent alteration of neuronal signaling pathways.</p>

<p>TCH-165 is a synthetic compound, which is derived from specialized chemical synthesis processes with precision-targeted interactions in biochemical systems. This compound operates primarily through its capacity to modulate specific signaling pathways, affecting cellular responses at the molecular level. It is engineered to interact selectively with key proteins, altering their activity and thereby influencing downstream biological effects.</p>

<p>Ensartinib is a small-molecule inhibitor of anaplastic lymphoma kinase (ALK), which is a receptor tyrosine kinase. This product is derived from chemical synthesis and classified as a targeted cancer therapy. Ensartinib’s mode of action involves the selective inhibition of ALK phosphorylation, which blocks downstream signaling pathways involved in cell proliferation and survival.</p>

<p>2-[1-[(2-Amino-7H-purin-6-yl)amino]ethyl]-5-methyl-3-(2-methylphenyl)quinazolin-4-one is a synthetic pharmaceutical compound, classified as a small molecule inhibitor. It is derived from a combination of purine and quinazoline structures, typically synthesized through multi-step organic processes. This compound exhibits its mode of action by specifically targeting and inhibiting certain key enzymes or receptors within cellular pathways, potentially interfering with aberrant signaling processes. Through this mechanism, it can modulate biological activity, offering a pathway to correct dysregulated cellular environments.</p>

<p>Beraprost sodium is a synthetic analog of prostacyclin, which is derived from chemical synthesis. It acts by binding to the prostacyclin (IP) receptors on the surface of vascular endothelial cells and platelets, leading to an increase in cyclic adenosine monophosphate (cAMP) levels. This biochemical cascade results in vasodilation, inhibition of platelet aggregation, and anti-proliferative effects on smooth muscle cells.</p>

<p>Imidazo[1,2-a]pyridin-2(3H)-one is a heterocyclic compound, which is a member of the imidazopyridine class. This compound is synthesized through various organic reactions involving the cyclization of precursor molecules, often incorporating nitrogen atoms into its ring structure. Its mode of action typically involves interaction with specific biological targets, such as receptors or enzymes, where it can modulate physiological responses. The compound acts through binding at allosteric sites, often influencing the activity of central nervous system receptors or enzymes involved in cellular signaling pathways.</p>

<p>Please enquire for more information about TJ191 including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>Cbp/P300-in-3 is a small molecule inhibitor, which is synthesized in vitro. It functions by selectively inhibiting the CBP/p300 family of histone acetyltransferases (HATs), essential regulatory proteins involved in chromatin remodeling and transcriptional activation. The inhibitor binds to the active site of these enzymes, hindering their activity, thereby disrupting the acetylation of histones and other substrates.</p>

<p>Please enquire for more information about Nsah including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>RVT 501 is a biochemical reagent, which is derived from synthetic organic compounds with high specificity. Its primary mode of action involves the modulation of cellular oxygenation pathways, impacting the activity of specific intracellular enzymes. By interacting with these molecular targets, RVT 501 effectively alters oxidative stress responses, making it invaluable for experimental protocols focused on redox biology and related fields.</p>

<p>CYM 50769 is an agricultural fungicide, which is a synthetic chemical compound designed to protect crops from fungal infections. It originates from extensive laboratory research and development processes aimed at targeting and neutralizing specific fungal threats that affect agricultural yield and quality. The mode of action of CYM 50769 involves the inhibition of essential fungal metabolic pathways, thereby preventing the growth and proliferation of the fungus. This mechanism disrupts the pathogen's ability to reproduce and colonize plant tissues, effectively controlling the spread of the disease.</p>

<p>Dihydrocyclosporin A is an immunosuppressant, which is a cyclic undecapeptide derived from fungal metabolites, specifically from the soil fungus Tolypocladium inflatum. This compound functions through the inhibition of calcineurin, which is a crucial phosphatase involved in the activation of T-cells. By binding to the intracellular protein cyclophilin, Dihydrocyclosporin A forms a complex that inhibits calcineurin activity, subsequently blocking the transcription of interleukin-2 and other cytokines essential for T-cell proliferation.</p>

<p>AVN-492 is an anti-inflammatory compound, derived from specific medicinal plant sources. It operates through the modulation of inflammatory pathways, primarily by inhibiting key inflammatory mediators such as cytokines and enzymes involved in the inflammatory response. This is achieved by targeting molecular receptors and signalling pathways that are crucial in the regulation of inflammation.</p>

<p>Penicillin (human) is a beta-lactam antibiotic, which is derived from the Penicillium fungi. Its mode of action involves inhibiting the synthesis of peptidoglycan, an essential component of bacterial cell walls. This disruption in cell wall synthesis leads to cell lysis and ultimately bacterial cell death, making it particularly effective against Gram-positive bacteria.</p>

<p>1-[4-[6-[6-[(2R)-2-(3-Fluorophenyl)pyrrolidin-1-yl]imidazo[1,2-b]pyridazin-3-yl]pyridin-2-yl]pyridin-2-yl]piperidin-4-ol is a bioactive small molecule, typically synthesized in laboratories focusing on medicinal chemistry. This compound is specifically designed to interact with biochemical targets, usually proteins or receptors, to modulate their activity. Its mode of action involves binding to specific sites on these targets, potentially leading to inhibition, activation, or alteration of the target's natural function, depending on the desired therapeutic outcome. The applications of this compound are mainly situated in the realm of drug discovery and development, serving as a lead or candidate in the pursuit of effective therapies for conditions that involve the targeted pathways or receptors. Researchers analyze such compounds to assess their efficacy, selectivity, and therapeutic potential in disease models, which is critical in the preclinical stage of drug development.</p>

<p>Procaterol is a bronchodilator, which is a synthetic beta-2 adrenergic agonist. It is derived through chemical processes designed to specifically target the beta-2 adrenergic receptors located in the bronchial smooth muscle. The mode of action involves the activation of these receptors, which leads to the relaxation of bronchial smooth muscles. This relaxation effect facilitates the widening of airways, improving airflow and respiratory function.</p>

<p>Calcitonin (salmon) trifluoroacetate is a synthetic peptide analogue of the naturally occurring hormone calcitonin. It is derived from salmon, which is a rich source of calcitonin known for its higher potency compared to human calcitonin. This peptide functions by inhibiting osteoclast activity, which are the cells responsible for bone resorption. It achieves this by binding to specific receptors on osteoclasts, thus reducing bone turnover and lowering calcium levels in the blood.</p>

<p>Ns-3-008 hydrochloride is a synthetic research compound, which is derived from laboratory-based chemical synthesis. It acts primarily as an inhibitor of specific biological targets, potentially interfering with cellular signaling pathways. The mode of action of Ns-3-008 hydrochloride often involves binding to and inhibiting key enzymes or receptors that play critical roles in disease-related processes.</p>

<p>MSX-122 is a small-molecule inhibitor, which is synthetically derived through pharmaceutical research. It functions as an antagonist to hypoxia-inducible factor-1α (HIF-1α), a transcription factor pivotal in cellular response to low oxygen conditions. By inhibiting HIF-1α, MSX-122 effectively disrupts the transcriptional activation of genes involved in angiogenesis, metabolism, and survival pathways that are often upregulated in cancerous tissues.</p>

<p>Ent-ticagrelor is a chirally pure pharmaceutical compound, categorized as a P2Y12 receptor antagonist, derived synthetically. This stereoisomer exemplifies the principle of stereochemistry in drug development, focusing on molecular specificity. Its mode of action involves selective binding to the P2Y12 adenosine diphosphate (ADP) receptors on platelets. This binding effectively inhibits the ADP-mediated activation of the GPIIb/IIIa receptor complex, which is crucial for platelet aggregation and clot formation.</p>

<p>Namitecan is a semi-synthetic camptothecin derivative, derived primarily from the bark of the Camptotheca acuminata tree, a source known for potent antitumor properties. Its mode of action involves the inhibition of DNA topoisomerase I, an enzyme critical for DNA replication. By stabilizing the covalent bond between DNA and topoisomerase I during the replication process, Namitecan effectively induces DNA damage, resulting in apoptosis of rapidly dividing tumor cells.</p>

<p>GSK J4 HCl is a small-molecule inhibitor, which is derived from synthetic chemistry methods, designed specifically to target the histone demethylase JMJD3/UTX. This compound functions by inhibiting the activity of the enzyme, effectively modulating epigenetic modifications through its influence on histone demethylation processes.</p>

<p>Lin28-let-7a antagonist 1 is a small molecule inhibitor, which is a chemically synthesized compound with significant therapeutic potential. It acts by targeting the Lin28/let-7 axis, a critical regulatory pathway involved in cellular processes such as development, metabolism, and tumorigenesis. The source of this antagonist is a synthetic, rationally designed compound, optimized for high specificity and potency.</p>

<p>N-Acetylpurinomycin is an antibiotic compound, which is a naturally occurring substance derived from microbial sources, specifically certain strains of the Streptomyces genus. The mode of action of N-Acetylpurinomycin involves inhibition of protein synthesis by targeting ribosomal RNA, thereby disrupting the translation process in bacterial cells. This mechanism is akin to several aminoglycoside antibiotics, whereby binding to the ribosome interferes with the fidelity of mRNA translation, leading to the incorporation of incorrect amino acids into proteins and the inhibition of bacterial growth.</p>

<p>NCX1022 is a novel anti-inflammatory compound, which is a nitric oxide-releasing glucocorticoid. This product originates from the integration of glucocorticoids, known for their potent immunosuppressive and anti-inflammatory properties, with nitric oxide (NO) donors. The mode of action involves the dual-release mechanism where the glucocorticoid exerts its effects by binding to the intracellular glucocorticoid receptor, inhibiting the transcription of pro-inflammatory cytokines, while the nitric oxide component facilitates vasodilation and additional anti-inflammatory effects through the modulation of blood flow and reduction of oxidative stress.</p>

<p>Non-transportable inhibitor of GLT-1 glutamate transporter</p>

<p>ZnAF-2 is a specialized chemical compound known as a zinc-based antimicrobial agent. It is synthesized through a controlled chemical process involving zinc ions coordinated with specific ligand structures, which contribute to its stability and reactivity. The primary mode of action for ZnAF-2 involves the disruption of microbial cellular structures, specifically targeting cell wall synthesis and membrane integrity. This mechanism allows it to effectively inhibit the growth and proliferation of a wide range of pathogenic microorganisms, including bacteria and fungi.</p>

<p>CUDC-427 is a small-molecule inhibitor of apoptosis proteins (IAP), which is a synthetic compound sourced from the design and synthesis of targeted anticancer agents. Its primary mode of action involves the selective inhibition of IAPs, particularly cIAP1 and cIAP2. This inhibition leads to the activation of caspases and subsequent induction of apoptosis in cancer cells.</p>

<p>IQ 1S is an advanced writing instrument, which is an innovation in sensor-integrated pens developed from cutting-edge optoelectronic engineering. With the integration of highly sensitive, miniaturized sensors and a sophisticated feedback system, IQ 1S provides users with real-time analysis and metadata collection while writing. This instrument utilizes a combination of pressure sensors and accelerometers to capture comprehensive writing data, including pressure, angle, and velocity.</p>

<p>Y-33075 dihydrochloride is a potent selective Rho-associated kinase (ROCK) inhibitor, which is synthesized chemically. It specifically targets ROCK enzymes involved in the regulation of the cytoskeleton by phosphorylating proteins that control smooth muscle contraction, cell migration, and other critical cellular processes. Y-33075 dihydrochloride works by inhibiting the ROCK pathway, leading to alterations in cell shape, motility, and apoptosis.</p>

<p>[(2R)-2-[(E)-But-2-enoyl]oxy-3-hexadecoxypropyl] 2-(trimethylazaniumyl)ethyl phosphate is a synthetic phospholipid, which is derived from designed chemical synthesis. With its amphiphilic nature, this compound integrates into lipid bilayers, enhancing membrane permeability. It serves as an effective vector for drug delivery, facilitating the transport of therapeutic agents across cellular membranes.</p>

<p>Ifn alpha-ifnar-in-1 hydrochloride is a synthetic small molecule, which is derived from chemical synthesis with a focus on disrupting specific cytokine signaling pathways. This compound operates by selectively inhibiting the interaction between interferon-alpha (IFN-α) and its receptor, IFNAR, thereby blocking downstream JAK-STAT signaling pathways. The blockade of this signaling cascade is crucial in modulating immune responses, which are often dysregulated in various pathologies.</p>

<p>BIIE 0246 is a selective neuropeptide Y (NPY) Y2 receptor antagonist, which is a synthetic compound with specific applications in neuroscience research. This product is derived from combinatorial chemistry techniques that allow for precise structure-activity relationship studies.</p>

<p>Protac BRD9 Degrader-1 is a small molecule degrader, which is a bifunctional molecule derived from proteolysis-targeting chimera (PROTAC) technology. It operates by harnessing the ubiquitin-proteasome system to selectively degrade the BRD9 protein. The molecule consists of two ligands: one binds to the target protein, BRD9, and the other recruits an E3 ubiquitin ligase. This forms a ternary complex, leading to the ubiquitination and subsequent degradation of BRD9.</p>

<p>PF-3758309 is a small molecule inhibitor, which is identified as a product of synthetic chemical engineering. It acts as a potent inhibitor of the PAK kinases, particularly PAK4, a family of serine/threonine kinases involved in cytoskeletal dynamics, cell motility, survival, and proliferation. These kinases are overexpressed in various types of cancer, making them attractive targets for therapeutic intervention.</p>

<p>Pyr6 is a small molecule inhibitor, which is derived from synthetic organic chemistry with a specific mode of action targeting signaling pathways. Its main mechanism involves the inhibition of transient receptor potential (TRP) channels, specifically TRPV6, which plays a critical role in calcium influx in cells. By inhibiting TRPV6, Pyr6 effectively disrupts calcium signaling, which is pivotal in various cellular processes, including proliferation and differentiation.</p>

<p>1-Desoxymethylsphingosine is a synthetic compound, which is derived from sphingosine analogs, designed for research purposes. As a chemical entity, it is typically synthesized in laboratories specializing in lipid chemistry. The mode of action of 1-Desoxymethylsphingosine involves the inhibition of enzymes involved in sphingolipid metabolism, primarily targeting the sphingosine kinase pathway. This inhibition affects the regulation of bioactive sphingolipids, which play crucial roles in cell signaling and apoptosis.</p>

<p>RMC-4550 is an adhesive compound, which is a synthetic formulation with high-performance bonding capabilities. It is derived from an optimized blend of polymers, designed to enhance its adhesion and tensile strength on diverse substrates. The mode of action involves forming molecular interactions and mechanical interlocks with the surfaces it bonds, which provides exceptional resistance to environmental degradation and mechanical stress.</p>

<p>2-(Phosphonomethyl)-pentanedioic acid tetrasodium is a synthetic compound, which is an organophosphorus chemical designed for specific biochemical applications. Its source lies in the realm of chemical synthesis involving the phosphorylation of organic moieties, leading to its unique structural configuration.</p>

<p>Please enquire for more information about Fosteabine including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>The USP7/USP47 inhibitor is a small molecule inhibitor, which is a synthetic compound designed to interrupt specific protein functions. It is sourced through chemical synthesis processes that enable precise modulation of the ubiquitin-proteasome system. The mode of action involves the inhibition of USP7 (ubiquitin-specific protease 7) and USP47, which are enzymes with deubiquitinating activity. By preventing these enzymes from removing ubiquitin tags from substrate proteins, the inhibitor promotes protein degradation.</p>